Stand-alone canaloplasty and trabeculotomy with the Omni surgical system showed positive real-world outcomes in reducing IOP and medication use, according to a study published in American Journal of Ophthalmology.
“This study is both significant and unique, given its real-world design and considerably larger scale compared to previous studies on stand-alone canaloplasty and trabeculotomy with Omni,” Jaime Dickerson, vice president of medical and clinical affairs at Sight Sciences, told Healio. “It offers strong evidence reaffirming the long-term effectiveness of stand-alone